Metabolites and Age-Related Macular Degeneration
Author Information
Author(s): Liu Zhen-Yu, Zhang Hang, Sun Xiu-Li, Liu Jian-Ying
Primary Institution: Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University
Hypothesis
This study aimed to assess the effect of plasma metabolites on age-related macular degeneration (AMD) and its two subtypes using a bidirectional two-sample Mendelian randomization approach.
Conclusion
The study supported the effect of plasma metabolites on AMD, providing novel insights for clinical diagnosis and prevention strategy.
Supporting Evidence
- 13 metabolites were found to have significant causal associations with AMD.
- 1-stearoyl-GPE (18:0) and X-11,850 exhibited protective effects on AMD.
- Gulonate and mannonate increased the risk of AMD.
- AMD reduced the level of androstenediol (3β,17β) monosulfate.
- AMD increased the level of stearoyl sphingomyelin (d18:1/18:0).
Takeaway
This study looked at how certain substances in our blood might affect a common eye disease that can make it hard to see when people get older.
Methodology
The study used a bidirectional two-sample Mendelian randomization analysis with genome-wide association studies summary statistics.
Potential Biases
The study did not identify significant horizontal pleiotropy or heterogeneity in the results.
Limitations
The dataset is predominantly focused on European samples, limiting applicability to other ethnicities, and the study could not stratify AMD by other factors.
Participant Demographics
The study included 3,763 cases and 205,359 controls of European ancestry.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website